Imatinib mesylate induces clinical remission in rheumatoid arthritis

被引：17
作者：
Pereira, Ivanio [1 ]
Fialho, Sonia [1 ]
Castro, Glaucio [1 ]
Zimmermann, Adriana [1 ]
机构：
[1] Univ Fed Santa Catarina, Univ Hosp, Rheumatol Sect, BR-88032001 Florianopolis, SC, Brazil
来源：
JOINT BONE SPINE | 2010年 / 77卷 / 04期
关键词：
Imatinib mesylate; Rheumatoid arthritis; Chronic myeloid leukaemia; Treatment; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; EFFICACY; PATIENT;
D O I：
10.1016/j.jbspin.2010.03.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：372 / 373
页数：2
相关论文
共 10 条
  • [1] Almeida A, 2009, ACTA MEDICA PORT, V22, P537
  • [2] Ames PRJ, 2008, J RHEUMATOL, V35, P1682
  • [3] Maintained Efficacy of the Tyrosine Kinase Inhibitor Imatinib Mesylate in a Patient With Rheumatoid Arthritis
    Eklund, Kari K.
    Lindstedt, Ken
    Sandler, Charlotta
    Kovanen, Petri T.
    Laasonen, Leena
    Juurikivi, Annika
    Wolff, Henrik
    Mykkaenen, Marko
    Joensuu, Heikki
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2008, 14 (05) : 294 - 296
  • [4] Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases
    Eklund, KK
    Joensuu, H
    [J]. ANNALS OF MEDICINE, 2003, 35 (05) : 362 - 367
  • [5] Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia:: a potential approach to the treatment of arthritis
    Juurikivi, A
    Sandler, C
    Lindstedt, KA
    Kovanen, PT
    Juutilainen, T
    Leskinen, MJ
    Mäki, T
    Eklund, KK
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1126 - 1131
  • [6] Koyama Kensuke, 2007, Mod Rheumatol, V17, P306, DOI 10.1007/s10165-007-0592-9
  • [7] Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia
    Miyachi, K
    Ihara, A
    Hankins, RW
    Murai, R
    Maehiro, S
    Miyashita, H
    [J]. CLINICAL RHEUMATOLOGY, 2003, 22 (4-5) : 329 - 332
  • [8] Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
    Tebib, Jacques
    Mariette, Xavier
    Bourgeois, Pierre
    Flipo, Rene-Marc
    Gaudin, Philippe
    Le Loet, Xavier
    Gineste, Paul
    Guy, Laurent
    Mansfield, Colin D.
    Moussy, Alain
    Dubreuil, Patrice
    Hermine, Olivier
    Sibilia, Jean
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (03)
  • [9] Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway
    Terabe, Fumitaka
    Kitano, Masayasu
    Kawai, Mari
    Kuwahara, Yusuke
    Hirano, Toru
    Arimitsu, Junsuke
    Hagihara, Keisuke
    Shima, Yoshihito
    Narazaki, Masashi
    Tanaka, Toshio
    Kawase, Ichiro
    Sano, Hajime
    Ogata, Atsushi
    [J]. MODERN RHEUMATOLOGY, 2009, 19 (05) : 522 - 529
  • [10] Resolution of Rheumatoid Arthritis Symptoms With Imatinib Mesylate
    Vernon, Matthew R.
    Pearson, Larry
    Atallah, Ehab
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2009, 15 (05) : 267 - 267
1